Company Filing History:
Years Active: 2003-2014
Title: Richard Hiipakka: Innovator in Pharmaceutical Compounds
Introduction
Richard Hiipakka is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various health conditions. With a total of 4 patents to his name, Hiipakka's work has the potential to impact the treatment of serious diseases.
Latest Patents
Hiipakka's latest patents include innovative compounds known as Liver X receptor agonists. These compounds are defined by a complex formula and are designed to lower blood cholesterol levels while also treating conditions such as cancer, atherosclerosis, diabetes, Alzheimer's disease, and corneal arcus. Another significant patent involves methods and compositions for regulating 5-alpha reductase activity. This includes pharmaceutical compositions that may contain a 5-alpha reductase inhibitor, which can be derived from natural and synthetic sources, including flavonoids and fatty acids. The combination of testosterone or DHT with these inhibitors is also explored in his work.
Career Highlights
Throughout his career, Richard Hiipakka has worked with reputable organizations such as Arch Development Corporation and the University of Chicago. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research.
Collaborations
Hiipakka has collaborated with notable colleagues, including Shutsung Liao and Dacheng Peng. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Richard Hiipakka's innovative work in pharmaceutical compounds showcases his dedication to improving health outcomes through scientific research. His contributions are significant in the ongoing battle against various diseases, and his patents reflect a commitment to advancing medical science.